ProFound Detection (V4.0)
by Icad, Inc.
510(k) K240417
ProFound Detection (V4.0) is a medical device (FDA Class II; FDA product code QDQ) made by Icad, Inc., cleared under FDA 510(k) K240417 on 8 Nov 2024, active as of 10 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK240417 | Date8 Nov 2024 | StatusActive |
Official records
- FDA 510(k) database K240417
From the FDA record
- Received by the FDA
- 13 Feb 2024
- FDA decision
- 8 Nov 2024 (Substantially Equivalent)
- FDA review time
- 269 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QDQ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2090
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K240417
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| ProFound Detection 4.0 | 4.0 | 00850008977541 | — | On the market |
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Transpara 1.7.0 by Screenpoint Medical B.V.
- Genius AI Detection 2.0 by Hologic, Inc.
- Median LCS (internal name) / eyonis LCS (trade name) (1.0) by Median Technologies
- Saige-Dx (3.1.0) by DEEPHEALTH
- MammoScreen® (5) by THERAPIXEL SA
- DeepHealth ProstateAI by Quantib B.V.
- Transpara by Screenpoint Medical B.V.
- Genius AI Detection by Hologic, Inc.
- Saige-Dx by DEEPHEALTH
- SMART-T Thyroid by See-Mode Technologies Pte, Ltd.